Article Figures & Tables
Figures
- Fig. 1.
Imaging the nuclear envelope by SEM and dSTORM. (A) SEM imaging is restricted to the nucleoplasmatic, nuclear-basket-containing, side, whereas dSTORM imaging is performed from the cytoplasmatic side, where the anchoring proteins are oriented in the direction of the coverglass. Schematically, an electron beam and an objective are depicted to symbolize SEM and dSTORM imaging, respectively. (B) SEM image of a folded nuclear envelope. (C) Influence of the pixel binning used to reconstruct the super-resolved dSTORM image on resolution, that is, the visualization of the central channel of the NPC. Scale bar: 200 nm.
- Fig. 2.
Correlative dSTORM-SEM of NPCs. (A) dSTORM image of the central channel labeled with WGA–Alexa-647, (B) corresponding SEM image of the nucleoplasmatic side of the nuclear envelope and (C) overlay of the dSTORM and SEM images. (D) Detailed overlay of a different area, highlighting that some NPCs are not labeled by WGA–Alexa-647. (E) The integral membrane protein gp210 was labeled using immunofluorescence with Alexa 647. (F) Corresponding SEM image, (G) overlay of dSTORM and SEM image and (H) overlay of the detailed eightfold structure of the outer gp210 ring. (I,J) Examples of NPCs revealing a ninefold symmetrical structure of gp210 proteins (Hinshaw and Milligan, 2003). Scale bars: 250 nm (A–C), 100 nm (D), 500 nm (E–G), 200 nm (H–J).
- Fig. 3.
Localization statistic of gp210 proteins labeled with a primary antibody and a secondary Alexa-647-labeled F(ab′)2 fragment. The mean localization number was determined as 274±4 for whole NPCs (an example is shown in the inset) (A), 35.1±0.5 for single domains (dashed ring in inset) within the eightfold NPC structure (B), and 8.1±0.2 for isolated fluorescence signals (spots, dashed ring in inset) found in NPCs corresponding to an individual F(ab′)2 fragment (C) (mean±s.e.m.). Scale bars, 20 nm.
Keywords
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
2020 at The Company of Biologists
Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.
Mole – The Corona Files
"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."
Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.
Cell scientist to watch – Christine Faulkner
In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.
Read & Publish participation extends worldwide
“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”
Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.
JCS and COVID-19
For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.
If you have any questions or concerns, please do not hestiate to contact the Editorial Office.